Hologic
Hologic Fiscal Q1 Revenues Fall 27 Percent as COVID-19 Assay Sales Continue Slide
The firm beat predictions for the quarter on the strength of its other molecular diagnostics business, and it predicts double-digit revenue growth for the year.
Hologic Aims to Expand Global Reach With Focus on Women's Health
At the JP Morgan Healthcare conference, CEO Steve MacMillan especially noted Africa as an underserved market for women's health.
Hologic Preliminary Fiscal Q1 Revenues Down 27 Percent on COVID Sales Decline
The firm expects to beat the analysts' average estimate on the strength of its Diagnostics business, excluding COVID-19 testing.
360Dx Top 30 Drops 37 Percent in 2022
All but one of the 30 companies in the list saw their share prices decline year over year with several firms' stock prices retreating more than 80 percent.
In Brief This Week: PerkinElmer, Hologic, Quest Diagnostics, Natera, More
News items for the week of Nov. 14, 2022.
Apr 6, 2022
Oct 4, 2021
Sep 22, 2021